Patterns of spinal cord atrophy by metrizamide CT.
Forty patients with cervical myelopathy underwent high-resolution computed tomography (CT) with intrathecal administration of metrizamide for evaluation of cervical spinal cord atrophy. Thirty of them showed evidence of either focal atrophic distortion or generalized accentuation of the anatomic surface features of the spinal cord. Patients with a Chiari malformation or syringomyelia were excluded. The characteristic features in cervical spondylosis and canal deformity include flattening of the ventral surface of the cord, central infolding, beaking of the lateral funiculi, and wasting of the dorsal surface of the cord. Patients with motor neuron disease showed a combination of anterolateral and posterolateral atrophy reflecting underlying degeneration of the anterior horn cells and/or corticospinal tracts, respectively. Those with monomelic motor neuron disease had a striking ipsilateral hemiatrophy of the spinal cord. Among those presenting with spastic paraparesis, seven with clinically definite multiple sclerosis showed diffuse atrophy or focal degeneration due to a localized plaque of demyelination. Two cases of cord neoplasm showed atrophy secondary to ascending or descending degeneration of the long tracts.
D001284:Atrophy; D006801:Humans; D008793:Metrizamide; D009046:Motor Neurons; D009103:Multiple Sclerosis / Q000000981:diagnostic imaging; D009468:Neuromuscular Diseases / Q000000981:diagnostic imaging; D013116:Spinal Cord / Q000473:pathology*; D013117:Spinal Cord Compression / Q000000981:diagnostic imaging; D013128:Spinal Osteophytosis / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed / Q000379:methods*
D008793:Metrizamide